Metabomed
Yavne
About Metabomed
Metabomed designs drugs designed treats cancer. Its drugs target the reprogrammed cancer cell's metabolism to halt their growth, enabling patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $30.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2019)
- Website: metabomed.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/metabomed-102567 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.